Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all?
Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all?
复制标题
前列腺癌的生物标志物：谁将从局部治疗中受益，谁患有隐匿性全身性疾病，谁需要治疗？
DOI：
10.2217/bmm.13.127
复制
发表时间：
2013
影响因子：
2.2
通讯作者：
Camphausen,KevinA
中科院分区：
文献类型：
--
作者：
Citrin,Deborah;Camphausen,KevinA
